JD Supra: Mergers

SEPTEMBER 10, 2024

For the sixth consecutive year, Dechert is the contributing editor of the International Comparative Legal Guide - Private Equity.

Private Equity 152

Private Equity Equities Government IT 152

JD Supra: Mergers

MAY 22, 2024

McGuireWoods recently held its 20th Annual Healthcare Private Equity and Finance Conference (HCPE Conference) in Chicago. The conference drew more than 1,000 professionals from private equity funds, senior and mezzanine lenders, and investment banks, as well as C-level executives, consultants and principals in the healthcare industry.

Private Equity 165

Private Equity Healthcare Finance Finance 165

JD Supra: Mergers

AUGUST 15, 2024

private equity investors has reached an all-time high, and with capital on the sideline ready to deploy, pressure to get deals done is on the rise. Although the U.S. healthcare industry has weathered the storm over the past couple of years, we may be reaching calmer waters in the coming months. Dry powder held by U.S.

Private Equity 177

Private Equity Healthcare Equities M&A 177

JD Supra: Mergers

SEPTEMBER 23, 2024

On August 31, the last day of its 2024 Legislative Session, the California Legislature approved Assembly Bill 3129 (Wood), which provides for notification to and review by the Attorney General of health care transactions involving private equity groups and hedge funds.

Private Equity 171

Private Equity Equities Healthcare Funds 171

JD Supra: Mergers

SEPTEMBER 26, 2024

The California Legislature recently passed Assembly Bill 3129 (“AB 3129” or the “Bill”), which, if signed by California Governor Gavin Newsom, would increase oversight of healthcare entity transactions involving private equity investment. Governor Newsom has until September 30, 2024, to sign or veto the Bill.

Private Equity 177

Private Equity Healthcare Equities Investment 177

JD Supra: Mergers

AUGUST 5, 2024

The Massachusetts legislative session for 2024 has come to a close without the passage of a bill that would have targeted private equity in healthcare.

Private Equity 171

Private Equity Healthcare Equities Funds 171

JD Supra: Mergers

OCTOBER 15, 2024

In last year’s Looking Ahead Guide, we had predicted the 2024 deal landscape would improve over 2023 year-end results in terms of number of closed buyout transactions, transaction values, and exits. This seems to be the case, as we see initial signs of an improving landscape after a stronger Q2.

Private Equity 177

Private Equity Equities Insurance Valuation 177

JD Supra: Mergers

OCTOBER 11, 2024

State legislatures across the country are beginning to consider and debate the pros and cons of passing laws aimed at regulating private equity’s role in the healthcare industry. Originally published in The Journal Record - October 10, 2024. By: McAfee & Taft

Private Equity 177

Private Equity Healthcare Equities 177

JD Supra: Mergers

AUGUST 1, 2024

Over the last decade, private equity firms have acquired healthcare companies, hospitals, and clinics at an increasing rate. In fact, in those ten years, private equity firms have spent roughly $1 trillion on an estimated 8,000 healthcare deals. This trend is only expected to increase through 2024.

Private Equity 159

Private Equity Healthcare Equities Portfolio 159

JD Supra: Mergers

AUGUST 1, 2024

At the end of last year, Holland & Knight predicted that "the current enforcement environment will continue into 2024 and will focus heavily on the healthcare industry, along with private equity transactions or 'roll-ups.' 15, 2023.)

Private Equity 171

Private Equity Healthcare Equities 171

JD Supra: Mergers

JULY 25, 2024

On July 18, 2024, the Massachusetts Senate passed S. 2871, An Act Enhancing the Health Care Market Review Process (the Bill), to increase oversight of healthcare transactions involving private equity firms, real estate investment trusts, and management services organizations (MSOs).

Private Equity 171

Private Equity Healthcare Equities Management 171

JD Supra: Mergers

OCTOBER 2, 2024

On September 28, 2024, Governor Newsom vetoed Assembly Bill No. 3129 (AB 3129), which would have required private equity groups and hedge funds to obtain the Attorney General’s written consent at least 90 days prior to acquisitions or changes of control of certain health care facilities, provider groups, and other providers.

Private Equity 171

Private Equity Equities Healthcare Funds 171

JD Supra: Mergers

OCTOBER 1, 2024

On September 28, 2024, California Governor Gavin Newsom vetoed California Assembly Bill 3129 (the Bill). The Bill, if enacted, would have imposed new notice and consent requirements for private equity investors involved in healthcare transactions. By: Robinson+Cole Health Law Diagnosis

Private Equity 165

Private Equity Healthcare Equities Investors 165

TechCrunch: M&A

OCTOBER 17, 2024

Zuora, a company selling software to help businesses manage their subscription-based services, has agreed to be acquired by private equity firms GIC and Silver Lake for $1.7 It’ll take Zuora, which is currently publicly traded, private. Tien […] © 2024 TechCrunch. All rights reserved.

Management 322

Management Private Equity Public Trading Equities 322

JD Supra: Mergers

JANUARY 14, 2025

On December 30, 2024, both the Massachusetts House of Representatives and the Massachusetts Senate enacted House Bill 5159 (H.5159), 5159), and Governor Maura Healey signed it on January 8, 2025.

Private Equity 159

Private Equity Healthcare Equities Investment 159

JD Supra: Mergers

MAY 30, 2024

The Federal Trade Commission’s (FTC) push against private equity roll-ups has hit a snag. Judge Hoyt found that the FTC had not adequately alleged that Welsh Carson “is violating” or “is about to violate” antitrust laws, as required under.

Private Equity 188

Private Equity Equities Trading 188

JD Supra: Mergers

SEPTEMBER 5, 2024

On August 31, 2024, California’s legislature passed Assembly Bill 3129 (“AB 3129”), which will be enacted if approved by California Governor, Gavin Newsom.

Private Equity 177

Private Equity Healthcare Equities Funds 177

JD Supra: Mergers

DECEMBER 18, 2024

administration on dealmaking, the dynamics of transatlantic M&A, private equity exits, and Mario Draghis proposals to reshape the European merger review landscape. In our biannual M&A trends report we explore the possible impact of the new U.S.

M&A 177

M&A Private Equity Mergers Equities 177

JD Supra: Mergers

MARCH 8, 2024

A recent government initiative announced on March 5, 2024 signals that more antitrust scrutiny for private equity firms and asset managers is on the horizon. By: Paul Hastings LLP

Private Equity 165

Private Equity Equities Healthcare Asset Management 165

JD Supra: Mergers

JULY 1, 2025

Department of Justice’s (DOJ’s or Department’s) National Security Division (NSD or Division) announced they had declined to prosecute the private equity firm White Deer Management LLC for violations of U.S. This marks the first declination by the DOJ since the Department released its Merger and Acquisitions Policy in March 2024.

M&A 130

M&A Mergers and Acquisitions Private Equity Mergers 130

JD Supra: Mergers

MARCH 13, 2024

Private equity investment in the health care sector continues to be a significant area of focus for the U.S. On March 5, 2024, the Federal Trade Commission (FTC) hosted a public workshop to “examine the role of private equity investment in health care markets” (the FTC workshop). antitrust agencies.

Private Equity 159

Private Equity Equities Investment Trading 159

JD Supra: Mergers

JUNE 12, 2024

On June 6, 2024, California Attorney General Rob Bonta announced that he led a multistate coalition of eleven (11) state attorneys general in in submitting a comment letter (the “Comment Letter”) in response to the Federal Trade Commission, the U.S. Department of Justice, and the U.S. By: Sheppard Mullin Richter & Hampton LLP

Private Equity 171

Private Equity Healthcare Equities Trading 171

TechCrunch: M&A

JULY 18, 2024

Canadian private equity firm PartnerOne paid $28.2 HeadSpin’s 2023 revenue was $21 million and its Q1 2024 revenue stood at $5 million, the […] © 2024 TechCrunch. HeadSpin’s 2023 revenue was $21 million and its Q1 2024 revenue stood at $5 million, the […] © 2024 TechCrunch. All rights reserved.

Private Equity 302

Private Equity Valuation IT Capital 302

JD Supra: Mergers

MAY 29, 2024

In a decision with significant implications for private equity firms and minority investors, on May 13, 2024, the US District Court for the Southern District of Texas dismissed the Federal Trade Commission’s (FTC) suit against a fund of private equity firm Welsh, Carson, Anderson & Stowe (Welsh Carson) that is a minority investor in US Anesthesia (..)

Private Equity 171

Private Equity Equities Investors Funds 171

JD Supra: Mergers

JANUARY 23, 2025

PE deal activity: Deal activity was slightly down in 2024 with a 3% YoY decline, while deal value was up 14%. Transaction activity did not make the strong comeback dealmakers were hoping for in 2024 as investors navigated market uncertainty around rate cuts and the 2024 presidential election. By: Ropes & Gray LLP

Private Equity 177

Private Equity Equities Investors 177

Deal Lawyers

NOVEMBER 9, 2023

Dechert recently released its annual Global Private Equity Outlook, which reports the results of a survey of 100 senior-level executives within PE firms based around the globe with at least $1 billion in assets under management.

Private Equity 124

Private Equity Equities Shares Management 124

TechCrunch: M&A

OCTOBER 17, 2024

Website builder Squarespace is no longer a publicly traded company, after private equity firm Permira procured all remaining common stock in the firm. Permira first revealed plans to acquire Squarespace back in May, offering shareholders in the NYSE-traded company $44 per share — this equated to an equity valuation of $6.6

Private Equity 316

Private Equity Acquisitions Public Trading Valuation 316

JD Supra: Mergers

DECEMBER 20, 2024

At the start of 2024 private equity firms were hoping that market conditions would align in a way that would make it easier for them to exit their assets and realize above-market gains. By: A&O Shearman

Private Equity 137

Private Equity Equities IT 137

JD Supra: Mergers

OCTOBER 3, 2024

On 19 September 2024, we were once again delighted to assemble hundreds of healthcare professionals, investors, and industry changemakers at The Langham in London for our annual Healthcare Private Equity (HPE) Europe conference. By: McDermott Will & Emery

Private Equity 177

Private Equity Healthcare Equities Investors 177

JD Supra: Mergers

JUNE 3, 2024

California’s AB 3219, which would require private equity firms and hedge funds to obtain prior approval to consummate certain healthcare-related transactions, is now one step closer to becoming law following the State Assembly’s May 22, 2024 passage of the pending legislation.

Private Equity 171

Private Equity Healthcare Equities Funds 171

JD Supra: Mergers

MAY 17, 2024

Anesthesia Partners (USAP) and Welsh Carson, a private equity fund that owns 23 percent of USAP and controls two of 14 board seats, engaged in an anticompetitive scheme to acquire and consolidate anesthesia practices in Texas partially survived motions to dismiss by the two defendants. May 13, 2024), under Section 13(b) of the.

Private Equity 171

Private Equity Equities Trading Funds 171

JD Supra: Mergers

AUGUST 21, 2024

An estimated 75% of private equity transactions and 64% of larger strategic acquirers use it. RWI is a well-established tool in the merger and acquisition (M&A) toolbox for both private equity and strategic buyers. Broad coverage and competitive pricing have been the theme for 2024. RWI has been widely adopted.

Insurance 171

Insurance Private Equity Mergers and Acquisitions Equities 171

TechCrunch: M&A

MAY 6, 2024

As DocuSign reportedly explores a sale to private equity, it’s acquiring a company itself. The purchase comes as DocuSign makes increasing investments […] © 2024 TechCrunch. The purchase comes as DocuSign makes increasing investments […] © 2024 TechCrunch. All rights reserved. For personal use only.

Private Equity 327

Private Equity Management Sale Equities 327

JD Supra: Mergers

DECEMBER 21, 2023

The Corporate Transparency Act (CTA) introduces beneficial ownership reporting requirements effective January 1, 2024, for new and existing companies. The CTA reporting obligations also impact due diligence for mergers and acquisitions (M&A) and in-house formation of new entities.

Private Equity 171

Private Equity Funds Corporation Equities 171

JD Supra: Mergers

APRIL 29, 2024

On February 16, 2024, another Bill was introduced in California that could have significant implications on certain health care transactions.

Private Equity 177

Private Equity Equities Funds 177

JD Supra: Mergers

JULY 17, 2024

The general sentiment is that buyers have adapted to the current interest rates and are gritting their teeth and pressing forward—especially private equity (PE) investors who need to deploy their “dry powder.”. Deal volume across the healthcare industry generally appears to have steadied despite headwinds.

Healthcare 192

Healthcare Private Equity Equities Investors 192

JD Supra: Mergers

MARCH 14, 2024

Heading into 2024, expectations for biotech venture capital (VC) and private equity (PE) investments were low following two lackluster years, but as we wrap up Q1, those expectations have been turned on their head after a strong start to the year. This leads us to question whether these early tailwinds are here to stay?

Private Equity 183

Private Equity Equities Capital Investment 183